VaxCyte(PCVX)
Focus: VaxCyte is a publicly traded biotechnology company focused on developing conjugate vaccines and protein-based vaccines, particularly for infectious diseases. With 1,001-5,000 employees, the company is scaling clinical operations across a pneumococcal vaccine pipeline.
Profile data last refreshed 5h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
63+55 this month
Hot — 75 jobs added in 30d
Net +55 (75 new, 20 removed). Aggressive expansion phase.
Should You Work at VaxCyte?
AI assessmentVaxCyte is a growth-stage vaccine specialist with meaningful clinical catalysts ahead, but cash burn rate and single-indication focus warrant caution about long-term runway.
Why Work Here
- High R&D intensity: $332M spend in FY 2025 signals deep investment in vaccine development and clinical execution.
- Growing headcount (1001-5000 range) with 53 active job openings indicates expansion phase, creating advancement opportunities.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
24 valent pneumococcal conjugate vaccine
Pneumococcal VaccinesClinical Trials (1)
NCT05266456Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
Phase 1/2Help build intelligence for VaxCyte
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.